In mid-June, Dr. Sun, Wei-Ting, Deputy Director of R&D at Honeybear Biosciences, was invited to give an educational lecture at Taipei Medical University (TMU). He provided a deep analysis of current research trends and market developments in the field of ADCs (Antibody Drug Conjugates), highlighting the unique features and advantages of Honeybear’s proprietary CoNectar® technology platform. His presentation aroused strong interest and active questions from the attending experts and students. Dr. Sun generously shared insights and offered valuable suggestions, earning high recognitions from both the organizers and the session moderator.
